Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size, Share & Trends Analysis Report by Component (Pumps, Oxygenators, Controllers, Cannulas, Accessories, Others), by Modality (Veno-Venous (VV), Veno-Arterial (VA), Arterio-Venous (AV)), Age Group, Technology, Patient Type, Application, End User and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035
|
Market Structure & Evolution |
|
|
Segmental Data Insights |
|
|
Demand Trends |
|
|
Competitive Landscape |
|
|
Strategic Development |
|
|
Future Outlook & Opportunities |
|
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size, Share, and Growth
The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing robust growth, with its estimated value of USD 0.4 billion in the year 2025 and USD 0.7 billion by the period 2035, registering a CAGR of 4.3%. Asia Pacific leads the market with market share of 51% with USD 0.2 billion revenue.
Mr. Marc Benedetti, President of Getinge Cardiopulmonary stated, “We are committed to innovation in ECMO technology as we are working to advance life-saving treatment in critical situations to provide patients faster and safer cardiopulmonary support in moments when every second counts.”
The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing positive growth due to increased prevalence of severe cardiac and respiratory failure and the increased use of ECMO in critical care and emergency medicine. ECMO anticipated expanding in critical care units globally due to improvements in portable ECMO systems and membrane oxygenators.
Further, North America is the leader in the ECMO machine market as it contains an advanced critical care infrastructure, high and robust adoption in tertiary hospitals, and a high amount of funding available for life-support technologies. Evidence of where ECMO is spotlighted is during the COVID-19 pandemic, which has included ECMO therapy to manage and treat patients with a severe respiratory condition when ventilators have proved inadequate, thereby accelerating the growth of the ECMO machine market.
Additionally, increasing government and private investments in critical care equipment is also benefitting the ECMO machine market. Increasing awareness of the life-saving potential of ECMO among healthcare providers and the growing availability of ECMO machines anticipated to equally strengthen demand in the future.
Moreover, companies such as Getinge, Medtronic, and Terumo are developing AI-enabled electronic monitoring (e-monitoring) systems and modular ECMO systems, which position the ECMO machine market to continue integration with next-generation critical care solutions.
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Dynamics and Trends
Driver: Expanding Use of Life-Saving, Portable, and Technologically Advanced Cardiopulmonary Support Systems
- ECMO machines are an increasingly important tool in critical care, as they can support heart and lung function for patients with life-threatening conditions. The reliance on ECMO is gaining traction due to the number of morbidities and imminent risks of morbidity we see today- the number of cases of severe respiratory illness, deteriorating heart failure, and possible intraoperative complications are soaring.
- Moreover, new ECMO systems have also become considerably more portable, safer, and smarter with their embedded sensors and AI-based control. Hospitals are also investing significantly into ECMO systems for their emergency preparedness initiatives, especially in light of COVID-19 and the demonstrated potential of ECMO to save lives.
Restraint: Complex Operation and High Cost Restricting Use to Specialized Centers
- The ECMO machine is an essential part of the care of patients with severe cardiac or respiratory failure; however, the utilization of the ECMO machine is limited to tertiary care centers largely due to the complexity of setup, the constant monitoring required and the expense involved of running an ECMO operation.
- Moreover, access to ECMO is further complicated because ECMO is a complex treatment modality that requires a trained and dedicated ECMO team to actually deliver ECMO, and there are very few hospitals and care facilities that have that capability. The resource demand (and human resource demand) poses a barrier to access to ECMO and has considerably limited the opportunity for the ECMO market to grow in the context of extended or other types of clinical care.
Opportunity: Technological Advancements and Rising Critical Care Investments Open Pathways for Market Expansion
- Ongoing advances in the design of ECMOs - in terms of compactness, advanced automation and usability - are improving the safety and delivery of life-sustaining therapies in intensive care units. Ongoing investments into critical care infrastructure and services in developing economies are creating opportunities for low ECMO utilization rates to rise towards global averages and potentially surpass them in non-tertiary settings.
- Further, the increasing burden of cardiopulmonary disease and heightened pandemic awareness of advanced respiratory therapies anticipated to ensure ongoing growth of ECMO systems and therapies. Partnerships and collaborations being formed between manufacturers and health systems are also developing training initiatives to promote ECMO competences and potential in low-resource countries.
Key Trend: Technological Streamlining, Mobility Enhancements, and Expanded Indications Drive Market Evolution
- Next-generation extracorporeal membrane oxygenation (ECMO) systems are becoming smaller, more portable, and more intuitive adding to their potential use in mobile units and inter-hospital transfer. With the new automation features and built-in monitoring, systems are reducing his dependence on specialized personnel.
- Moreover, the expanded use of ECMO in protocols for severe ARDS, cardiac arrest, and perioperative support is extending its indications as a clinical therapy. More awareness and better documentation of ECMO training programs anticipated to help further reduce the global shortage of qualified operators.
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Segmental Data
Oxygenators Maintain Dominance in Global Market amid Rising ECMO Adoption and Advancements in Membrane Technology
- Oxygenators still maintain a commanding place in the ECMO machine market due to the need to facilitate gas exchange during cardiopulmonary support. As membrane performance, biocompatibility, and durability improve, the results for patients and the duration of runs are increasing as well.
- Additionally, as the use of ECMO technologies increases in neonatal, pediatric and adult populations, the demand is continuing to increase. Manufacturers are continuing to also focus on the production of low-resistance oxygenators with heparin coatings, to reduce complications and to support longer ECMO runs.
Asia Pacific Dominates the Extracorporeal Membrane Oxygenation (ECMO) Machine Market, Driven by Expanding Critical Care Infrastructure and Rising Incidence of Cardiopulmonary Conditions
- The region's commitment to health system modernization and recent funding towards ICU capacity and assistive technologies for life-sustaining circulatory support is informing ECMO usage in China, India, Japan, and other regional markets. The increased use of ECMO is being propelled by a rising caseload of respiratory failure, cardiovascular disease, and complications of premature birth.
- Additionally, the development of ECMO training centers along with government endorsement is enabling a growing awareness of, and really improving the availability of and experienced use of ECMO. New local manufacturing and cost-saving innovations consolidate the regional market standing.
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Ecosystem
The extracorporeal membrane oxygenation (ECMO) machine market is highly consolidated, as has medium to high concentration. Tier 1 players such as Getinge AB, Fresenius Medical Care, and Medtronic are dominant through broad product portfolios covering multiple classifications and with multiple channels of distribution at a global level. Tier 2 market players such as Abiomed and LivaNova, are dominant in the region, while Tier 3 covers specialists and emergent business. The presence of moderately concentrated buyers in hospitals and critical care centers, along with a supplier concentration level since the technology is complex and there are limited manufacturers, is moderate according to Porter's five forces.
Recent Development and Strategic Overview:
- In July 2025, Getinge AB unveiled the new Cardiohelp XL ECMO System, raising the bar for mobility and digital support in critical care. The Cardiohelp XL comes equipped with AI-driven monitoring, an even lighter and more portable design, and an intuitive, larger touchscreen interface that guides workflows for setup and troubleshooting. With its built-in electronic gas blender, upgraded reliability, and integration of near-infrared spectroscopy (NIRS) for real-time oxygenation monitoring, clinicians can confidently manage ECMO support across the hospital or during transport-making fast, informed decisions.
- In June 2025, Medtronic launched the VitalFlow ECMO System, following its CE Mark approval in Europe. The VitalFlow platform is all about making ECMO therapy as streamlined and approachable as possible, featuring a configurable one-system solution with a fully integrated, intuitive interface that allows every ICU team member—no matter their experience level—to operate and manage ECMO confidently. VitalFlow’s modular architecture supports both bedside care and hospital transport, while its design-born through the Medtronic acquisition of MC3 Cardiopulmonary.
Report Scope
|
Attribute |
Detail |
|
Market Size in 2025 |
USD 0.4 Bn |
|
Market Forecast Value in 2035 |
USD 0.7 Bn |
|
Growth Rate (CAGR) |
4.3% |
|
Forecast Period |
2025 – 2035 |
|
Historical Data Available for |
2021 – 2024 |
|
Market Size Units |
USD Bn for Value Million Units for Volume |
|
Report Format |
Electronic (PDF) + Excel |
|
Regions and Countries Covered |
|||||
|
North America |
Europe |
Asia Pacific |
Middle East |
Africa |
South America |
|
|
|
|
|
|
|
Companies Covered |
|||||
|
|
|
|
|
|
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Segmentation and Highlights
|
Segment |
Sub-segment |
|
By Component |
|
|
By Modality |
|
|
By Age Group |
|
|
By Technology |
|
|
By Patient Type |
|
|
By Application |
|
|
By End User |
|
Frequently Asked Questions
The global extracorporeal membrane oxygenation (ECMO) machine market was valued at USD 0.4 Bn in 2025
The global extracorporeal membrane oxygenation (ECMO) machine market industry is expected to grow at a CAGR of 4.3% from 2025 to 2035
ECMO machines are in higher demand because more people have serious heart and lung issues, and new technology is making these lifesaving devices easier and safer for hospitals to use.
In terms of extracorporeal membrane oxygenation (ECMO) machines, the oxygenators accounted for the major share in 2025.
Asia Pacific is a more attractive region for vendors.
Key players in the global extracorporeal membrane oxygenation (ECMO) machines market include prominent companies such as Abbott Laboratories, Abiomed Inc., ALung Technologies, Inc., Andocor N.V., Cardiohelp (Getinge), Eurosets S.r.l., Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, LivaNova PLC, MC3 Cardiopulmonary, Medos Medizintechnik AG, Medtronic plc, Microport Scientific Corporation, Nipro Corporation, OriGen Biomedical, Inc., Senko Medical Instrument Mfg. Co., Ltd., Spectrum Medical, Terumo Corporation, Xenios AG (a Fresenius Medical Care Company), and other key players, along with several other key players.
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook
- 2.1.1. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2025-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Extracorporeal Membrane Oxygenation (ECMO) Machine Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Source Roadmap and Developments
- 3.4. Trade Analysis
- 3.4.1. Import & Export Analysis, 2025
- 3.4.2. Top Importing Countries
- 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
- 3.5.1. Manufacturer
- 3.5.2. Supply Chain
- 3.5.3. End Consumer
- 3.6. Raw Material Analysis
- 3.1. Extracorporeal Membrane Oxygenation (ECMO) Machine Industry Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Expanding Use of Life-Saving, Portable, and Technologically Advanced Cardiopulmonary Support Systems
- 4.1.2. Restraints
- 4.1.2.1. Complex Operation and High Cost Restricting Use to Specialized Centers
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.4.1. Raw Components Sourcing
- 4.4.2. Manufacturing and Processing
- 4.4.3. Wholesalers/ E-commerce Platform
- 4.4.4. End-use/ Customers
- 4.5. Cost Structure Analysis
- 4.5.1. Parameter’s Share for Cost Associated
- 4.5.2. COGP vs COGS
- 4.5.3. Profit Margin Analysis
- 4.6. Pricing Analysis
- 4.6.1. Regional Pricing Analysis
- 4.6.2. Segmental Pricing Trends
- 4.6.3. Factors Influencing Pricing
- 4.7. Porter’s Five Forces Analysis
- 4.8. PESTEL Analysis
- 4.9. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Demand
- 4.9.1. Historical Market Size – (Volume - Million Units and Value - USD Bn), 2021-2024
- 4.9.2. Current and Future Market Size – (Volume - Million Units and Value - USD Bn), 2025–2035
- 4.9.2.1. Y-o-Y Growth Trends
- 4.9.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Component
- 6.1. Key Segment Analysis
- 6.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by Component, 2021-2035
- 6.2.1. Pumps
- 6.2.2. Oxygenators
- 6.2.3. Controllers
- 6.2.4. Cannulas
- 6.2.5. Accessories
- 6.2.6. Others
- 7. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Modality
- 7.1. Key Segment Analysis
- 7.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by Modality, 2021-2035
- 7.2.1. Veno-Venous (VV)
- 7.2.2. Veno-Arterial (VA)
- 7.2.3. Arterio-Venous (AV)
- 8. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Age Group
- 8.1. Key Segment Analysis
- 8.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by Age Group, 2021-2035
- 8.2.1. Neonates
- 8.2.2. Pediatrics
- 8.2.3. Adults
- 9. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Technology
- 9.1. Key Segment Analysis
- 9.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by Technology, 2021-2035
- 9.2.1. Portable ECMO Systems
- 9.2.2. Static ECMO Systems
- 10. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Patient Type
- 10.1. Key Segment Analysis
- 10.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by Patient Type, 2021-2035
- 10.2.1. Acute Patients
- 10.2.2. Chronic Patients
- 11. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by Application
- 11.1. Key Segment Analysis
- 11.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by Application, 2021-2035
- 11.2.1. Respiratory
- 11.2.2. Cardiac
- 11.2.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
- 11.2.4. Others
- 12. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, by End User
- 12.1. Key Segment Analysis
- 12.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by End User, 2021-2035
- 12.2.1. Hospitals
- 12.2.2. Ambulatory Surgical Centers
- 12.2.3. Specialty Clinics
- 12.2.4. Emergency Care
- 12.2.5. Others
- 13. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, by Region, 2021-2035
- 13.2.1. North America
- 13.2.2. Europe
- 13.2.3. Asia Pacific
- 13.2.4. Middle East
- 13.2.5. Africa
- 13.2.6. South America
- 14. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, 2021-2035
- 14.3.1. Component
- 14.3.2. Modality
- 14.3.3. Age Group
- 14.3.4. Technology
- 14.3.5. Patient Type
- 14.3.6. Application
- 14.3.7. End User
- 14.3.8. Country
- 14.3.8.1. USA
- 14.3.8.2. Canada
- 14.3.8.3. Mexico
- 14.4. USA Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 14.4.1. Country Segmental Analysis
- 14.4.2. Component
- 14.4.3. Modality
- 14.4.4. Age Group
- 14.4.5. Technology
- 14.4.6. Patient Type
- 14.4.7. Application
- 14.4.8. End User
- 14.5. Canada Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 14.5.1. Country Segmental Analysis
- 14.5.2. Component
- 14.5.3. Modality
- 14.5.4. Age Group
- 14.5.5. Technology
- 14.5.6. Patient Type
- 14.5.7. Application
- 14.5.8. End User
- 14.6. Mexico Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 14.6.1. Country Segmental Analysis
- 14.6.2. Component
- 14.6.3. Modality
- 14.6.4. Age Group
- 14.6.5. Technology
- 14.6.6. Patient Type
- 14.6.7. Application
- 14.6.8. End User
- 15. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, 2021-2035
- 15.3.1. Component
- 15.3.2. Modality
- 15.3.3. Age Group
- 15.3.4. Technology
- 15.3.5. Patient Type
- 15.3.6. Application
- 15.3.7. End User
- 15.3.8. Country
- 15.3.8.1. Germany
- 15.3.8.2. United Kingdom
- 15.3.8.3. France
- 15.3.8.4. Italy
- 15.3.8.5. Spain
- 15.3.8.6. Netherlands
- 15.3.8.7. Nordic Countries
- 15.3.8.8. Poland
- 15.3.8.9. Russia & CIS
- 15.3.8.10. Rest of Europe
- 15.4. Germany Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.4.1. Country Segmental Analysis
- 15.4.2. Component
- 15.4.3. Modality
- 15.4.4. Age Group
- 15.4.5. Technology
- 15.4.6. Patient Type
- 15.4.7. Application
- 15.4.8. End User
- 15.5. United Kingdom Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.5.1. Country Segmental Analysis
- 15.5.2. Component
- 15.5.3. Modality
- 15.5.4. Age Group
- 15.5.5. Technology
- 15.5.6. Patient Type
- 15.5.7. Application
- 15.5.8. End User
- 15.6. France Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.6.1. Country Segmental Analysis
- 15.6.2. Component
- 15.6.3. Modality
- 15.6.4. Age Group
- 15.6.5. Technology
- 15.6.6. Patient Type
- 15.6.7. Application
- 15.6.8. End User
- 15.7. Italy Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.7.1. Country Segmental Analysis
- 15.7.2. Component
- 15.7.3. Modality
- 15.7.4. Age Group
- 15.7.5. Technology
- 15.7.6. Patient Type
- 15.7.7. Application
- 15.7.8. End User
- 15.8. Spain Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.8.1. Country Segmental Analysis
- 15.8.2. Component
- 15.8.3. Modality
- 15.8.4. Age Group
- 15.8.5. Technology
- 15.8.6. Patient Type
- 15.8.7. Application
- 15.8.8. End User
- 15.9. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.9.1. Country Segmental Analysis
- 15.9.2. Component
- 15.9.3. Modality
- 15.9.4. Age Group
- 15.9.5. Technology
- 15.9.6. Patient Type
- 15.9.7. Application
- 15.9.8. End User
- 15.10. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.10.1. Country Segmental Analysis
- 15.10.2. Component
- 15.10.3. Modality
- 15.10.4. Age Group
- 15.10.5. Technology
- 15.10.6. Patient Type
- 15.10.7. Application
- 15.10.8. End User
- 15.11. Poland Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.11.1. Country Segmental Analysis
- 15.11.2. Component
- 15.11.3. Modality
- 15.11.4. Age Group
- 15.11.5. Technology
- 15.11.6. Patient Type
- 15.11.7. Application
- 15.11.8. End User
- 15.12. Russia & CIS Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.12.1. Country Segmental Analysis
- 15.12.2. Component
- 15.12.3. Modality
- 15.12.4. Age Group
- 15.12.5. Technology
- 15.12.6. Patient Type
- 15.12.7. Application
- 15.12.8. End User
- 15.13. Rest of Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 15.13.1. Country Segmental Analysis
- 15.13.2. Component
- 15.13.3. Modality
- 15.13.4. Age Group
- 15.13.5. Technology
- 15.13.6. Patient Type
- 15.13.7. Application
- 15.13.8. End User
- 16. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. East Asia Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, 2021-2035
- 16.3.1. Component
- 16.3.2. Modality
- 16.3.3. Age Group
- 16.3.4. Technology
- 16.3.5. Patient Type
- 16.3.6. Application
- 16.3.7. End User
- 16.3.8. Country
- 16.3.8.1. China
- 16.3.8.2. India
- 16.3.8.3. Japan
- 16.3.8.4. South Korea
- 16.3.8.5. Australia and New Zealand
- 16.3.8.6. Indonesia
- 16.3.8.7. Malaysia
- 16.3.8.8. Thailand
- 16.3.8.9. Vietnam
- 16.3.8.10. Rest of Asia-Pacific
- 16.4. China Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Component
- 16.4.3. Modality
- 16.4.4. Age Group
- 16.4.5. Technology
- 16.4.6. Patient Type
- 16.4.7. Application
- 16.4.8. End User
- 16.5. India Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Component
- 16.5.3. Modality
- 16.5.4. Age Group
- 16.5.5. Technology
- 16.5.6. Patient Type
- 16.5.7. Application
- 16.5.8. End User
- 16.6. Japan Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Component
- 16.6.3. Modality
- 16.6.4. Age Group
- 16.6.5. Technology
- 16.6.6. Patient Type
- 16.6.7. Application
- 16.6.8. End User
- 16.7. South Korea Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.7.1. Country Segmental Analysis
- 16.7.2. Component
- 16.7.3. Modality
- 16.7.4. Age Group
- 16.7.5. Technology
- 16.7.6. Patient Type
- 16.7.7. Application
- 16.7.8. End User
- 16.8. Australia and New Zealand Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.8.1. Country Segmental Analysis
- 16.8.2. Component
- 16.8.3. Modality
- 16.8.4. Age Group
- 16.8.5. Technology
- 16.8.6. Patient Type
- 16.8.7. Application
- 16.8.8. End User
- 16.9. Indonesia Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.9.1. Country Segmental Analysis
- 16.9.2. Component
- 16.9.3. Modality
- 16.9.4. Age Group
- 16.9.5. Technology
- 16.9.6. Patient Type
- 16.9.7. Application
- 16.9.8. End User
- 16.10. Malaysia Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.10.1. Country Segmental Analysis
- 16.10.2. Component
- 16.10.3. Modality
- 16.10.4. Age Group
- 16.10.5. Technology
- 16.10.6. Patient Type
- 16.10.7. Application
- 16.10.8. End User
- 16.11. Thailand Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.11.1. Country Segmental Analysis
- 16.11.2. Component
- 16.11.3. Modality
- 16.11.4. Age Group
- 16.11.5. Technology
- 16.11.6. Patient Type
- 16.11.7. Application
- 16.11.8. End User
- 16.12. Vietnam Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.12.1. Country Segmental Analysis
- 16.12.2. Component
- 16.12.3. Modality
- 16.12.4. Age Group
- 16.12.5. Technology
- 16.12.6. Patient Type
- 16.12.7. Application
- 16.12.8. End User
- 16.13. Rest of Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 16.13.1. Country Segmental Analysis
- 16.13.2. Component
- 16.13.3. Modality
- 16.13.4. Age Group
- 16.13.5. Technology
- 16.13.6. Patient Type
- 16.13.7. Application
- 16.13.8. End User
- 17. Middle East Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, 2021-2035
- 17.3.1. Component
- 17.3.2. Modality
- 17.3.3. Age Group
- 17.3.4. Technology
- 17.3.5. Patient Type
- 17.3.6. Application
- 17.3.7. End User
- 17.3.8. Country
- 17.3.8.1. Turkey
- 17.3.8.2. UAE
- 17.3.8.3. Saudi Arabia
- 17.3.8.4. Israel
- 17.3.8.5. Rest of Middle East
- 17.4. Turkey Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Component
- 17.4.3. Modality
- 17.4.4. Age Group
- 17.4.5. Technology
- 17.4.6. Patient Type
- 17.4.7. Application
- 17.4.8. End User
- 17.5. UAE Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Component
- 17.5.3. Modality
- 17.5.4. Age Group
- 17.5.5. Technology
- 17.5.6. Patient Type
- 17.5.7. Application
- 17.5.8. End User
- 17.6. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Component
- 17.6.3. Modality
- 17.6.4. Age Group
- 17.6.5. Technology
- 17.6.6. Patient Type
- 17.6.7. Application
- 17.6.8. End User
- 17.7. Israel Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Component
- 17.7.3. Modality
- 17.7.4. Age Group
- 17.7.5. Technology
- 17.7.6. Patient Type
- 17.7.7. Application
- 17.7.8. End User
- 17.8. Rest of Middle East Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Component
- 17.8.3. Modality
- 17.8.4. Age Group
- 17.8.5. Technology
- 17.8.6. Patient Type
- 17.8.7. Application
- 17.8.8. End User
- 18. Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, 2021-2035
- 18.3.1. Component
- 18.3.2. Modality
- 18.3.3. Age Group
- 18.3.4. Technology
- 18.3.5. Patient Type
- 18.3.6. Application
- 18.3.7. End User
- 18.3.8. Country
- 18.3.8.1. South Africa
- 18.3.8.2. Egypt
- 18.3.8.3. Nigeria
- 18.3.8.4. Algeria
- 18.3.8.5. Rest of Africa
- 18.4. South Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Component
- 18.4.3. Modality
- 18.4.4. Age Group
- 18.4.5. Technology
- 18.4.6. Patient Type
- 18.4.7. Application
- 18.4.8. End User
- 18.5. Egypt Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Component
- 18.5.3. Modality
- 18.5.4. Age Group
- 18.5.5. Technology
- 18.5.6. Patient Type
- 18.5.7. Application
- 18.5.8. End User
- 18.6. Nigeria Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Component
- 18.6.3. Modality
- 18.6.4. Age Group
- 18.6.5. Technology
- 18.6.6. Patient Type
- 18.6.7. Application
- 18.6.8. End User
- 18.7. Algeria Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Component
- 18.7.3. Modality
- 18.7.4. Age Group
- 18.7.5. Technology
- 18.7.6. Patient Type
- 18.7.7. Application
- 18.7.8. End User
- 18.8. Rest of Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Component
- 18.8.3. Modality
- 18.8.4. Age Group
- 18.8.5. Technology
- 18.8.6. Patient Type
- 18.8.7. Application
- 18.8.8. End User
- 19. South America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Central and South Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (Volume - Million Units and Value - USD Bn), Analysis, and Forecasts, 2021-2035
- 19.3.1. Component
- 19.3.2. Modality
- 19.3.3. Age Group
- 19.3.4. Technology
- 19.3.5. Patient Type
- 19.3.6. Application
- 19.3.7. End User
- 19.3.8. Country
- 19.3.8.1. Brazil
- 19.3.8.2. Argentina
- 19.3.8.3. Rest of South America
- 19.4. Brazil Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Component
- 19.4.3. Modality
- 19.4.4. Age Group
- 19.4.5. Technology
- 19.4.6. Patient Type
- 19.4.7. Application
- 19.4.8. End User
- 19.5. Argentina Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Component
- 19.5.3. Modality
- 19.5.4. Age Group
- 19.5.5. Technology
- 19.5.6. Patient Type
- 19.5.7. Application
- 19.5.8. End User
- 19.6. Rest of South America Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Component
- 19.6.3. Modality
- 19.6.4. Age Group
- 19.6.5. Technology
- 19.6.6. Patient Type
- 19.6.7. Application
- 19.6.8. End User
- 20. Key Players/ Company Profile
- 20.1. Abbott Laboratories
- 20.1.1. Company Details/ Overview
- 20.1.2. Company Financials
- 20.1.3. Key Customers and Competitors
- 20.1.4. Business/ Industry Portfolio
- 20.1.5. Product Portfolio/ Specification Details
- 20.1.6. Pricing Data
- 20.1.7. Strategic Overview
- 20.1.8. Recent Developments
- 20.2. Abiomed Inc.
- 20.3. ALung Technologies, Inc.
- 20.4. Andocor N.V.
- 20.5. Cardiohelp (Getinge)
- 20.6. Eurosets S.r.l.
- 20.7. Fresenius Medical Care AG & Co. KGaA
- 20.8. Getinge AB
- 20.9. Hemovent GmbH
- 20.10. LivaNova PLC
- 20.11. MC3 Cardiopulmonary
- 20.12. Medos Medizintechnik AG
- 20.13. Medtronic plc
- 20.14. Microport Scientific Corporation
- 20.15. Nipro Corporation
- 20.16. OriGen Biomedical, Inc.
- 20.17. Senko Medical Instrument Mfg. Co., Ltd.
- 20.18. Spectrum Medical
- 20.19. Terumo Corporation
- 20.20. Xenios AG (a Fresenius Medical Care Company)
- 20.21. Other key Players
- 20.1. Abbott Laboratories
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase and Others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players product portfolio
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources includes primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
